New trial data show mixed findings for omega-3s
Results of STRENGTH Trial with Omega-3 Fatty Acids Question Validity of REDUCE-It Trial | Pri-Med
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia | NEJM
STRENGTH Secondary Analysis Bolsters Case Against Cardiovascular Benefit of Omega-3s – Consult QD
REDUCE-IT Archives - Medical Conferences
Omega-3 fish oil supplements: Can they reduce triglycerides, risk of heart disease and improve metabolism? | Health and Wellness News - The Indian Express
Two Landmark Studies Shed New Light-and Shadow- on Omega-3s for CVD - Holistic Primary Care
IJMS | Free Full-Text | Omega-3 Polyunsaturated Fatty Acids—Vascular and Cardiac Effects on the Cellular and Molecular Level (Narrative Review)
Flow chart of participants in the Omega-3 to Reduce the Incidence of... | Download Scientific Diagram
Study design for REDUCE-IT. | Download Scientific Diagram
Meta-analysis of 17 clinical trials using omega-3 fatty acids in patients with cardiovascular disease - Atherosclerosis
The REDUCE-IT Trial: A New Hope for Heart Health – Premier Catch
Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease - YouTube
A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021 | SpringerLink
Nutrients | Free Full-Text | Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021
Sultania Cardiovascular Sciences - Ascend- Omega 3 Trial.. Among diabetic patients with no known CVD, omega-3 fatty acid supplementation was not beneficial. Omega-3 fatty acids failed to reduce the incidence of major
Omega-3 (Fish Oil)
Omega-3 fatty acids and the heart: New evidence, more questions - Harvard Health
Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk Reduction - ScienceDirect
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer | NEJM
Contrasting results of REDUCE-IT and STRENGTH trials of Omega 3 – All About Cardiovascular System and Disorders
CardsJC: STRENGTH Trial Journal Club - Cardionerds
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT | Journal of the American College of Cardiology
Does omega-3 reduce cardiovascular disease? Comparing major trials REDUCE IT, VITAL, and STRENGTH
Omega-3 supplementation does not reduce liver fat in overweight but healthy men: Blackmores-backed trial
REDUCE-IT (Vascepa) vs. STRENGTH (Epanova)- Why the Different Results? - NutritionHeart.com
